FDA Drug recall D-0258-2021
Meclizine HCl Tablets, USP, 12.5 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of…
- FDA Drug
- Class II
- terminated
- Published 2021-02-24
On 2021-02-24 the FDA classified a Class II recall of Meclizine HCl Tablets, USP, 12.5 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of… by Wilshire Pharmaceuticals, citing failed Dissolution Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0258-2021 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-02-04 |
| Published | 2021-02-24 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Wilshire Pharmaceuticals |
| Distribution | FL, TX |
Product
Meclizine HCl Tablets, USP, 12.5 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-129-01
Reason
Failed Dissolution Specifications
Identifiers
| code_info | Lot #: 18030318, Exp 03/2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0258-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.